Harnessing regulatory T cells to suppress asthma: From Potential to therapy

American Journal of Respiratory Cell and Molecular Biology

Volumn 43, Issue 5, 2010, Pages 511-519

  Thorburn, Alison N ^a   Hansbro, Philip M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Asthma; Forkhead box p3; Immunoregulatory therapy; Regulatory t cell

Indexed keywords

5' NUCLEOTIDASE; ACTIVIN A; B7 ANTIGEN; BIOLOGICAL MARKER; CD103 ANTIGEN; CD137 ANTIGEN; CD39 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FIBRINOGEN LIKE PROTEIN 2; GALECTIN 1; GRANZYME; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 35; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 9; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUROPILIN 1; OX40 LIGAND; PERFORIN; PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ASTHMA; B LYMPHOCYTE; BIFIDOBACTERIUM ANIMALIS; CD25+ T LYMPHOCYTE; CELL CONTACT; CELL PROLIFERATION; CYTOKINE RELEASE; DENDRITIC CELL; GENE; HELIGMOSOMOIDES POLYGYRUS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LITOMOSOIDES SIGMODONTIS; LYMPHOCYTE ACTIVATION GENE 3; MYCOBACTERIUM VACCAE; NATURAL KILLER T CELL; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; STREPTOCOCCUS PNEUMONIAE; TH17 CELL; TOXOPLASMA GONDII; ANIMAL; IMMUNOLOGY;

ANIMALS; ASTHMA; BIOLOGICAL MARKERS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 78149274601     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0342TR     Document Type: Review

References (111)

1. Pene J, Chevalier S, Preisser L, Venereau E, Guilleux M-H, Ghannam S, Moles J-P, Danger Y, Ravon E, Lesaux S, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180:7423-7430.
2. Wakashin H, Hirose K, Maezawa Y, Kagami S-i, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178:1023-1032.
3. McKinley L, Alcorn JF, Peterson A, DuPont RB, Kapadia S, Logar A, Henry A, Irvin CG, Piganelli JD, Ray A, et al. Th17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008;181:4089-4097.
4. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582.
5. Yamamoto H, Okamoto Y, Horiguchi S, Kunii N, Yonekura S, Nakayama T. Detection of natural killer T cells in the sinus mucosa from asthmatics with chronic sinusitis. Allergy 2007;62:1451-1455.
6. Hamzaoui A, Rouhou SC, Graïri H, Abid H, Ammar J, Chelbi H, Hamzaoui K. NKT cells in the induced sputum of severe asthmatics. Mediators Inflamm 2006;2:71214.
7. + T cells. Proc Natl Acad Sci USA 2006;103:2782-2787.
8. Bratke K, Lommatzsch M, Julius P, Kuepper M, Kleine H, Luttmann W, Christian Virchow J. Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax 2007;62:168-175.
9. Davies JM. Altered immunoglobulin E diversity and regulation of allergic inflammation in asthma. Clin Exp Allergy 2009;39:455-457.
10. + regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007;148:53-63.
11. Mamessier E, Nieves A, Lorec A, Dupuy P, Pinot D, Pinet C, Vervloet D, Magnan A. T-cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy 2008;63:1202-1210.
12. hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007;119:1258.
13. high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation. Allergy 2008;63:67-74.
14. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363:608-615.
15. + regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004;34:1364-1372.
16. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-1575.
17. lo/- regulatory T cells in human allergic asthma. J Allergy Clin Immunol 2009;123:933-939.
18. Lal G, Bromberg JS. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009;114:3727-3735.
19. + regulatory T cells is interleukin 10 dependent. J Exp Med 2005;202:1539-1547.
20. + regulatory T cells. J Exp Med 2006;203:2649.
21. + regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 2008;122:617-624.
22. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Ruckert B, Mantel P-Y, Menz G, Akdis CA, Blaser K, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-1433.
23. Stock P, Akbari O, DeKruyff RH, Umetsu DT. Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol 2005;175:7380-7387.
24. + regulatory T cells and for expansion of these cells. J Immunol 2007;178:2018-2027.
25. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006;212:28-50.
26. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005;206:232-259.
27. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184:387-396.
28. Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008;28:468-476.
29. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002;420:502-507.
30. + TR cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-119.
31. Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007;26:579-591.
32. Wilson MS, Taylor MD, Balic A, Finney CAM, Lamb JR, Maizels RM. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 2005;202:1199-1212.
33. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005;35:2886-2895.
34. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta-1 production and responsiveness. J Exp Med 2002;196:237-246.
35. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000;164:183-190.
36. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DAA. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007;450:566-569.
37. Shalev I, Liu H, Koscik C, Bartczak A, Javadi M, Wong KM, Maknojia A, He W, Liu MF, Diao J, et al. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol 2008;180:249-260.
38. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004;21:589-601.
39. lo/- regulatory T cells in allergic asthma. Eur J Immunol 2008;38:2034-2045.
40. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005;174:1783-1786.
41. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen J-F, Enjyoji K, Linden J, Oukka M, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204:1257-1265.
42. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-1071.
43. Matriano JA, Socarras S, Streilein JW. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens: evidence that factor-mediated suppression silences cytotoxic T cell activity. J Immunol 1994;153:1505-1514.
44. + T cells. Blood 2007;109:2058-2065.
45. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre M-L, Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003;4:1206-1212.
46. + regulatory T cells abrogates their function in vivo. J Immunol 2006;177:4376-4383.
47. + regulatory T cell function. Science 2008;322:271-275.
48. Liang B, Workman C, Lee J, Chew C, Dale BM, Colonna L, Flores M, Li N, Schweighoffer E, Greenberg S, et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 2008;180:5916-5926.
49. Glinka Y, Chang Y, Prud'homme GJ. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand. Mol Ther 2006;14:578-587.
50. Milpied P, Renand A, Bruneau J, Mendes-Da-Cruz D, Jacquelin S, Asnafi V, Rubio M-T, MacIntyre E, Lepelletier Y, Hermine O. Neuropilin-1 is not a marker of human Foxp31 Treg. Eur J Immunol 2009;39:1466-1471.
51. Collison LW, Pillai MR, Chaturvedi V, Vignali DAA. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 2009;182:6121-6128.
52. + regulatory T cell function. Eur J Immunol 2004;34:2480-2488.
53. + T cells. Nat Immunol 2007;8:1353-1362.
54. Szymczak-Workman AL, Workman CJ, Vignali DAA. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J Immunol 2009;182:5188-5192.
55. - T Cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta1. J Immunol 2009;182:111-120.
56. + regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood 2008;112:2129-2138.
57. Minigo G, Woodberry T, Piera K, Salwati E, Tjitra E, Kenangalem E, Price R, Engwerda C, Anstey N, Plebanski M. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog 2009;5:e1000402.
58. + regulatory T cells. J Immunol 2007;179:2808-2814.
59. Gregori S, Mangia P, Bacchetta R, Tresoldi E, Kolbinger F, Traversari C, Carballido JM, de Vries JE, Korthauer U, Roncarolo M-G. An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells. J Exp Med 2005;201:1293-1305.
60. + T cells in vivo. J Immunol 2009;182:7490-7500.
61. Burmeister Y, Lischke T, Dahler AC, Mages HW, Lam K-P, Coyle AJ, Kroczek RA, Hutloff A. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol 2008;180:774-782.
62. Semitekolou M, Alissafi T, Aggelakopoulou M, Kourepini E, Kariyawasam HH, Kay AB, Robinson DS, Lloyd CM, Panoutsakopoulou V, Xanthou G. Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med 2009;206:1769-1785.
63. + natural regulatory T cells. Proc Natl Acad Sci USA 2009;106:12885-12890.
64. + regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am J Pathol 2008;173:154-160.
65. + regulatory T cells in vivo. J Immunol 2006;177:209-215.
66. Pino-Lagos K, Benson MJ, Noelle RJ. Retinoic acid in the immune system. Ann N Y Acad Sci 2008;1143:170-187.
67. + regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression. Int Immunol 2009;21:283-294.
68. Wohler J, Bullard D, Schoeb T, Barnum S. LFA-1 is critical for regulatory T cell homeostasis and function. Mol Immunol 2009;46:2424-2428.
69. + regulatory T cell-mediated suppression of antitumor immunity. Int J Cancer 2009;125:630-638.
70. + Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 2009;119:551-564.
71. + regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2007;319:41-52.
72. + T cells. Int Immunol 2002;14:1155-1167.
73. + regulatory T cells. Am J Respir Crit Care Med 2009;179:344-355.
74. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008;8:142-152.
75. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 2007;123:326-338.
76. + regulatory T cells suppress NKT cell functions. Cancer Res 2003;63:4516-4520.
77. + regulatory T cells? Eur J Immunol 2005;35:1193-1200.
78. + T cells selectively kill B lymphocytes. Blood 2006;107:3925-3932.
79. + regulatory T cells. J Immunol 2005;175:4180-4183.
80. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008;28:639-650.
81. Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and Toll-like receptors. Allergy 2008;63:1455-1463.
82. + T-cell development is regulated by at least 2 distinct mechanisms. Blood 2002;99:555-560.
83. + T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol 2006;177:7155-7163.
84. + regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 2006;17:2731-2741.
85. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, Ahrens B, Groneberg DA, Wahn U, Hamelmann E. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007;37:498-505.
86. Bashir MEH, Andersen P, Fuss IJ, Shi HN, Nagler-Anderson C. An enteric helminth infection protects against an allergic response to dietary antigen. J Immunol 2002;169:3284-3292.
87. Kitagaki K, Businga TR, Racila D, Elliott DE, Weinstock JV, Kline JN. Intestinal helminths protect in a murine model of asthma. J Immunol 2006;177:1628-1635.
88. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009;179:186-193.
89. Dittrich AM, Erbacher A, Specht S, Diesner F, Krokowski M, Avagyan A, Stock P, Ahrens B, Hoffmann WH, Hoerauf A, et al. Helminth infection with Litomosoides sigmodontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model. J Immunol 2008;180:1792-1799.
90. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002;8:625-629.
91. Trujillo-Vargas CM, Werner-Klein M, Wohlleben G, Polte T, Hansen G, Ehlers S, Erb KJ. Helminth-derived products inhibit the development of allergic responses in mice. Am J Respir Crit Care Med 2007;175:336-344.
92. Wohlleben G, Trujillo C, Muller J, Ritze Y, Grunewald S, Tatsch U, Erb KJ. Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 2004;16:585-596.
93. Mo HM, Lei JH, Jiang ZW, Wang CZ, Cheng YL, Li YL, Liu WQ. Schistosoma japonicum infection modulates the development of allergen-induced airway inflammation in mice. Parasitol Res 2008;103:1183-1189.
94. + regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 2006;176:5374-5387.
95. Preston JA, Essilfie A-T, Horvat JC, Wade MA, Beagley KW, Gibson PG, Foster PS, Hansbro PM. Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 2007;25:8154-8162.
96. Fenoy I, Giovannoni M, Batalla E, Martin V, Frank F, Piazzon I, Goldman A. Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice. Clin Exp Allergy 2009;155:275-284.
97. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218-230.
98. Stephens R, Randolph DA, Huang G, Holtzman MJ, Chaplin DD. Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J Immunol 2002;169:5458-5467.
99. Mehlhop P, van de Rijn M, Goldberg A, Brewer J, Kurup V, Martin T, Oettgen H. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997;94:1344-1349.
100. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001;107:531-534.
101. Vargas MH., Bernal-Alcántara DA, Vaca MA, Franco-Marina F, Lascurain R. Effect of BCG vaccination in asthmatic schoolchildren. Pediatr Allergy Immunol 2004;15:415-420.
102. Tang M. Probiotics and prebiotics: immunological and clinical effects in allergic disease. Nestle Nutr Workshop Ser Pediatr Program 2009;64:219-235.
103. Camporota L, Corkhill A, Long H, Lordan J, Stanciu L, Tuckwell N, Cross A, Stanford JL, Rook GAW, Holgate ST, et al. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J 2003;21:287-293.
104. Berth-Jones J, Arkwright PD, Marasovic D, Savani N, Aldridge CR, Leech SN, Morgan C, Clark SM, Ogilvie S, Chopra S, et al. Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy 2006;36:1115-1121. (Pubitemid 44342925)
105. Brothers S, Asher MI, Jaksic M, Stewart AW. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial. Clin Exp Dermatol 2009;34:770-775.
106. Lloyd CM, Hawrylowicz CM, Regulatory T. Cells in Asthma. Immunity 2009;31:438-449.
107. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119:780-789.
108. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, Rolland JM, Sandrini A. House dust mite sublingual immunotherapy: the role for transforming growth factor-β and functional regulatory T cells. Am J Respir Crit Care Med 2009;180:936-947.
109. Rolland JM, Gardner LM, O'Hehir RE. Allergen-related approaches to immunotherapy. Pharmacol Ther 2009;121:273-284.
110. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195:603-616.
111. Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, Adikibi T, Pridgeon C, Dallman M, Loke T-K, et al. Reversing the defective induction of IL-10 secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006;116:146-155.